Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 53 in last 24h · 115,243 total before filter · latest 55m ago
53last 24h
1810last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro323Earnings856M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: CVSSentiment:bullishneutralbearishshow all (incl. clickbait)
CVS’s Turnaround Faces Its Next Test
Barrons.com11d agoneutral
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.

FTC Reaches Settlement With CVS Health Over Insulin Prices
Barrons.com32d agoneutral
FTC Reaches Settlement With CVS Health Over Insulin Prices

The Federal Trade Commission announced a settlement with CVS Health’s pharmacy benefit manager business on Tuesday, the agency’s second major agreement this year with drug industry middlemen. Pharmacy-benefit managers, or PBMs, play a key role in negotiating with drug companies and selecting which prescription drugs will be covered by an insurance plan. In litigation filed in 2024 during the Biden administration, the commission alleged that rebates and fees collected by major PBMs from drug manufacturers artificially inflated the price of insulin.